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Case Report
Trousseau syndrome accompanied by cholangiocellular carcinoma:
Report of two 
Ryuichi Yamamoto1)＊, Shingo Kato1), Masatomo Takahashi1), 
Shino Ono1), Tomoya Sakurada1), Sumiko Nagoshi1), 
Ko Nishikawa2), Koji Yakabi1)
1)Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University
2)Department of the Gastroenterology, Ageo Central General Hospital
　Two cases of Trousseau syndrome associated with cholangiocellular carcinoma have been reported. The 
first patient, a 82-year-old woman, received chemotheraphy with weekly gemcitabine after the placement of a 
self - expanding metal stent for palliation of unresectable malignant biliary obstruction. She was admitted to our 
hospital because of dizziness in October 2010. A computed tomography (CT) showed fresh cerebral infarcts in the 
area of left middle cerebral artery and in the right temporal lobe. The final diagnosis was Trousseau syndrome 
accompanied by cholangiocellular carcinoma. She died 36 days after admission. The second patient, a 69 -year-
old woman, was admitted to our hospital because of disturbed consciousness. Her CT showed a cerebral infarct in 
the right temporal lobe. An enhanced abdominal CT showed a malignant  tumor in left hepatic lobe. A fine needle 
biopsy showed a cholangiocellular carcinoma. The final diagnosis was Trousseau syndrome accompanied by 
cholangiocellular carcinoma. She died 25 days after admission. 
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Introduction
The association between cancer and venous thrombosis 
was first recognized more than 100 years ago by 
Trousseau1). Cancer-related coagulopathy is known 
as Trousseau syndrome with a poor prognosis1, 2). 
The exact incidence of thromboembolic disease 
in association with cholangiocellular carcinoma is 
not known. However, the occurrence of Trousseau 
syndrome in the setting of advanced cholangiocellular 
carcinoma has rarely been reported3). In this report, 
the authors describe two patients with cholangiocellular 
carcinoma complicated by Trousseau syndrome, a 
clinical state consistent with disseminated intravascular 
coagulation (DIC).
Case reports
Case 1
A  8 2 - y e a r - o l d  w o m a n  w a s  d i a g n o s e d  w i t h 
cholangiocellular carcinoma involving the confluence 
of the right and left hepatic duct (T3N1M0,stage III ) 
(Fig. 1A, B, C). After placement of a self - expanding 
metallic stent for palliation of unresectable malignant 
biliary obstruction, she received chemotheraphy with 
gemcitabine. Gemcitabine was administered weekly 
as an intravenous 30 min infusion of 800 mg/m2 
for 3 consecutive weeks followed by 1-week of rest 
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(28 -day cycle). Her clinical condition was progressively 
getting worse despite six courses of chemotheraphy. 
She was admitted to our hospital because of dizziness 
in October 2010. A computed tomography(CT) showed 
fresh cerebral infarcts in the area of left middle cerebral 
artery and in the right temporal lobe (Fig. 2). The 
platelet count was 20.2×104/μL after chemotheraphy, 
but the platelet count was 5.7×104/μL and prothrombin 
time (PT) was 18 seconds (international normalized 
ratio (INR) was 1.56) on admission. The fibrinogen 
concentration was 101 mg/dL, and f ibrinogen 
degradation products (FDP) measured 80 μg/mL. 
These findings suggested DIC. The patient was treated 
with nafamostat mesilate. However, the patient died 
36 days after admission. The final diagnosis was 
Trousseau syndrome accompanied by cholangiocellular 
carcinoma.
Case 2
A 69-year-old woman was admitted to our hospital 
because of disturbed consciousness in May 2010. 
The Glasgow coma scale score upon admission was 
E2V2M4. The CT  showed a new broad cerebral infarct 
in the right temporal lobe (Fig. 3A). The patient’s MRI 
(dif fusion weighted sequence) demonstrated a new 
area of acute cerebral infarction in the right temporal 
lobe(Figure 3B). The platlet count was 6.3×104/μL, her 
PT was 17.3 seconds(INR was 1.43), the fibrinogen 
concentration was 259 mg/dL, and FDP measured 
80 μg/mL over. These findings suggested DIC. An 
enhanced abdominal CT showed a malignant tumor 
(10 cm×8.5 cm) in left hepatic lobe (Fig. 4A, B). Fine 
needle biopsy showed cholangiocellular carcinoma 
(Fig. 5). She was treated with nafamostat mesilate. 
Fig 1. Enhanced abdominal CT revealed a cholangiocelullar 
carcinoma centrally located in the right lobe of the 
liver (A) and dilatation of bi-lateral intrahepatic bile 
duct (B). An uncovered metallic stent was placed in 
the common bile duct in order to dilate the stenosis of 
right intrahepatic bile duct (C).
Fig 2. CT shows new cerebral infacts in the area of left 
middle cerebral artery and in the  right temporal lobe.
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However, she died 25 days after admission. The final 
diagnosis was Trousseau syndrome accompanied by 
cholangiocellular carcinoma.
Discussion
In 1865, Trousseau first described the relationship 
between neoplastic and thromboembolic disease4). 
Since then, a variety of thromboembolic events 
including spontaneous, recur rent or migrator y 
vascular thrombosis, microangiopathy, acute bleeding 
diathesis, and DIC in cancer patients have been termed 
Trousseau syndrome5).The prevalence of the syndrome 
was reported to be from 1% to 11%2). Non-bacterial 
thrombotic endocarditis, which has been reported to 
occur in up to 1.3% of patients dying of cancer, comes 
within the disease spectrum of Trousseau syndrome6). 
Several cases with occurrence of Trousseau syndrome 
in the setting of advanced cholangiocellular carcinoma 
Fig 3. CT shows a new broad cerebral infarct in the right temporal lobe (A). MRI (diffusion weighted sequence) demonstrated 
a new area of acute cerebral infarct in the right temporal lobe (B).
Fig 4. Enhanced abdominal CT showed a malignant tumor (10 cm×8.5 cm) in left hepatic lobe. The huge mass slightly 
enhanced on the arterial phase (A) and on the portal phase (B) revealed cholagiocellular carcinoma.
Fig 5. Photomicrograph of  l iver biopsy specimens. 
Moderately differentiated adenocarcinoma was shown 
in the hematoxylin -eosin stain (original magnification
×400). Pathological findings showed cholangiocellular 
carcinoma.
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have been reported3, 9, 10).
Routine coagulability tests were not helpful in the 
prediction of the development of thromboembolic 
disorder except for decreased platelet counts. Although 
screening tests for coagulation are optimized toward the 
detection of a hemorrhage, they are of limited value in 
the hypercoagulable state of patients with neoplasms7).
The full mechanism of cancer - induced coagulopathy 
has not yet been clarified. Recently, several mechanisms 
of activated coagulability associated with malignancy 
have been suggested. The release of thromboplastin-
like substances, fibrin deposition, direct factor X 
activation by tumor proteases, destruction of endothelial 
tissue, and tissue factors have been reported8).
Useful treatment for Trousseau syndrome has not 
yet been established. However, low molecular weight 
heparin, compared with unfractionated heparin, 
has been recommended because of the reduction 
of cancer-related mortality without the increase of 
thromboembolism and bleeding events2, 9).
Finally, Trousseau syndrome should be kept in 
mind in the case of multiple cerebral infarction of an 
unknown origin. A malignant status defines a patient’s 
prognosis in cases of Trousseau syndrome. 
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胆管細胞癌に伴ったTrousseau症候群の 2 例
山本　龍一 1)，加藤　真吾 1)，高橋　正朋 1)，大野　志乃 1)，櫻田　智也 1)，名越　澄子 1)，西川　稿 2)，
屋嘉比　康治 1)
　Trousseau症候群の原因となる悪性腫瘍には固形癌が多く，その中では婦人科腫瘍が最も多いとされており
胆管細胞癌に伴ったTrousseau症候群の報告は稀である．
　今回，われわれは脳梗塞で発見され胆管細胞癌に伴ったTrousseau症候群の2例を経験した．症例1は，82歳・
女性．胆管癌に伴う閉塞黄疸に対し内視鏡的胆管ステント留置後ゲムシタビン単独療法施行中であった．めまい
にて入院した．頭部CTにて左前頭葉の脳梗塞所見及び，採血検査にて血小板の低下が認められ，胆管癌に伴った
Trousseau症候群と診断した．nafamostat mesilateの持続点滴施行するも入院36日後死亡した．症例2は，69歳・
女性．意識レベル低下，歩行困難にて入院となった．頭部CTにて右前頭葉に多発脳梗塞所見，腹部造影CTにて
肝左葉に計10 cm大の造影効果の乏しい腫瘤を認め，腫瘍生検にて胆管細胞癌の診断であった．胆管細胞癌に伴っ
たTrousseau症候群と診断しnafamostat mesilateの持続点滴施行するも入院25日後死亡した．癌患者において脳梗
塞が発症した際は，常にTrousseau症候群の可能性を考慮すべきである．
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